Fortrea Holdings Inc. (FTRE) NASDAQ
13.22
+0.08(+0.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
13.22
+0.08(+0.61%)
Currency In USD
Address
8 Moore Drive
Durham, NC 27709
United States of America (the)
Phone
(480)-295-7600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
15000
First IPO Date
June 20, 2023
| Name | Title | Pay | Year Born |
| Anshul Thakral | Chief Executive Officer & Director | 1.69M | 1978 |
| Mark A. Morais | Chief Operating Officer & President of Clinical Services | 812,667 | 1977 |
| Jill McConnell | Chief Financial Officer | 817,879 | 1975 |
| Leonard Scott Dove | President of Clinical Pharmacology Services | 0 | 1974 |
| Robert Parks | Chief Accounting Officer | 0 | N/A |
| Hima Inguva | Head of Corporate Development | 0 | N/A |
| Oren J. Cohen | Chief Medical Officer | 0 | 1961 |
| Alejandro Martinez Galindo | Chief Information Officer | 0 | N/A |
| Dave Cooper | Chief Administrative Officer | 0 | N/A |
| Drayton Virkler | President & Chief Commercial Officer | 0 | N/A |
| Tracy H. Krumme | Senior Vice President of Investor Relations | 0 | 1968 |
| Agnieszka Gallagher | General Counsel & Corporate Secretary | 0 | 1974 |
| Sandy Kennedy | Chief Quality, Regulatory Affairs & Sustainability Officer | 0 | N/A |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.